January 17, 2012 – Accuray announced today that CHRISTUS MUGUERZA Hospital Alta Especialidad in Monterrey, Mexico, has starting treating patients with the CyberKnife Robotic Radiosurgery System. CHRISTUS MUGUERZA is the first center in Mexico now offering patients the benefits of the CyberKnife System to treat tumors anywhere in the body.
The CyberKnife System is a non-invasive option used to treat tumors and non-cancerous lesions anywhere in the body including intracranial, lung, head and neck, prostate and pancreatic tumors. The CyberKnife System delivers highly targeted and effective doses of radiation with the highest levels of accuracy enabling treatment of tumors close to critical, healthy structures. The CyberKnife System's unique ability to not only track, but also automatically correct, unpredictable movement of tumors during treatment minimizes radiation exposure to healthy tissues and helps patients avoid many side effects typically associated with other radiation option.
CHRISTUS MUGUERZA began treating patients in October 2011 and to date has treated eight patients with malignant tumors or non-cancerous lesions in the brain, head and neck, and kidneys using the CyberKnife System. The hospital's delivery of stereotactic body radiation therapy (SBRT) and stereotactic radiosurgery (SRS) using the CyberKnife System marks an important milestone for Accuray and offers cancer patients throughout the region a critical new treatment option.
"This installation marks the first use of the CyberKnife System in Mexico and demonstrates Accuray's commitment to growing our presence outside the U.S. in emerging markets," said Euan S. Thomson, Ph.D., president and CEO of Accuray. "To date, more than 100,000 patients worldwide have been treated with the CyberKnife Radiosurgery System and we are pleased to extend the benefits of stereotactic body radiation therapy and stereotactic radiosurgery to patients in Mexico."
For more information: www.accuray.com
April 25, 2024 
